Evidence map›Paper›PMID 22207758›Full record

ArticleThe Journal of biological chemistry2012

Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes.

Shi-Xiong Tan, Yvonne Ng, Christopher C Meoli, Ansu Kumar, Poh-Sim Khoo, Daniel J Fazakerley, Jagath R Junutula, Shireen Vali, David E James, Jacqueline Stöckli

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. The insulin signalling network.Nature metabolism · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The aetiology and molecular landscape of insulin resistance.Nature reviews. Molecular cell biology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Crosstalk in transition: the translocation of Akt.Journal of mathematical biology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shi-Xiong TanDiabetes and Obesity Research Program, The Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia.
Yvonne Ng
Christopher C Meoli
Ansu Kumar
Poh-Sim Khoo
Daniel J Fazakerley
Jagath R Junutula
Shireen Vali
David E James
Jacqueline Stöckli
Garvan Institute of Medical Research · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Akt plays a major role in insulin regulation of metabolism in muscle, fat, and liver. Here, we show that in 3T3-L1 adipocytes, Akt operates optimally over a limited dynamic range. This indicates that Akt is a highly sensitive amplification step in the pathway. With robust insulin stimulation, substantial changes in Akt phosphorylation using either pharmacologic or genetic manipulations had relatively little effect on Akt activity. By integrating these data we observed that half-maximal Akt activity was achieved at a threshold level of Akt phosphorylation corresponding to 5-22% of its full dynamic range. This behavior was also associated with lack of concordance or demultiplexing in the behavior of downstream components. Most notably, FoxO1 phosphorylation was more sensitive to insulin and did not exhibit a change in its rate of phosphorylation between 1 and 100 nm insulin compared with other substrates (AS160, TSC2, GSK3). Similar differences were observed between various insulin-regulated pathways such as GLUT4 translocation and protein synthesis. These data indicate that Akt itself is a major amplification switch in the insulin signaling pathway and that features of the pathway enable the insulin signal to be split or demultiplexed into discrete outputs. This has important implications for the role of this pathway in disease.

Indexed as

3T3-L1 CellsAdipocytesAnimalsAntibiotics, AntineoplasticComputer SimulationEnergy MetabolismGlucose Transporter Type 4Hypoglycemic AgentsInsulinInsulin Receptor Substrate ProteinsInsulin ResistanceMiceNonlinear DynamicsPhosphorylationPlatelet-Derived Growth FactorProto-Oncogene Proteins c-aktAkt1 protein, mouseAkt2 protein, mouseAntibiotics, AntineoplasticGlucose Transporter Type 4Hypoglycemic AgentsInsulinInsulin Receptor Substrate ProteinsIrs1 protein, mousemTOR protein, mousePlatelet-Derived Growth FactorProto-Oncogene Proteins c-aktRNA, Small InterferingSirolimusSlc2a4 protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID22207758
PMCPMC3307283
OpenAlexW2062030505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.